Status:
RECRUITING
The Immune Response to Stroke
Lead Sponsor:
University of Oslo
Conditions:
Stroke, Acute
Dementia
Eligibility:
All Genders
18+ years
Brief Summary
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and...
Eligibility Criteria
Inclusion
- Stroke \< 72 h
- Age \> 18 years
Exclusion
- Brain hemorrhage verified by CT or MRI scan
- Previous or present immunological disease or other serious comorbidity
- Ongoing immune respons after infection or vaccination \< 1 month
- Cognitive without ability to understand and/or give an informed consent to participate in the study
Key Trial Info
Start Date :
June 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 6 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05277129
Start Date
June 24 2021
End Date
June 6 2029
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Lørenskog, Norway